PL365602A1 - Kompozycje farmaceutyczne i sposoby ich stosowania - Google Patents

Kompozycje farmaceutyczne i sposoby ich stosowania

Info

Publication number
PL365602A1
PL365602A1 PL01365602A PL36560201A PL365602A1 PL 365602 A1 PL365602 A1 PL 365602A1 PL 01365602 A PL01365602 A PL 01365602A PL 36560201 A PL36560201 A PL 36560201A PL 365602 A1 PL365602 A1 PL 365602A1
Authority
PL
Poland
Prior art keywords
methods
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
PL01365602A
Other languages
English (en)
Inventor
Gary Maurice Dull
Original Assignee
Targacept, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept, Inc. filed Critical Targacept, Inc.
Publication of PL365602A1 publication Critical patent/PL365602A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL01365602A 2000-07-14 2001-05-04 Kompozycje farmaceutyczne i sposoby ich stosowania PL365602A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/616,187 US6743812B1 (en) 2000-07-14 2000-07-14 Pharmaceutical compositions and methods for use

Publications (1)

Publication Number Publication Date
PL365602A1 true PL365602A1 (pl) 2005-01-10

Family

ID=24468381

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365602A PL365602A1 (pl) 2000-07-14 2001-05-04 Kompozycje farmaceutyczne i sposoby ich stosowania

Country Status (13)

Country Link
US (1) US6743812B1 (pl)
EP (1) EP1317267A2 (pl)
JP (1) JP2004503589A (pl)
CN (1) CN1452486A (pl)
AU (1) AU2001261828A1 (pl)
BR (1) BR0112131A (pl)
CA (1) CA2415906A1 (pl)
HU (1) HUP0301594A2 (pl)
IL (1) IL153487A0 (pl)
NO (1) NO20030156L (pl)
PL (1) PL365602A1 (pl)
WO (1) WO2002005801A2 (pl)
ZA (1) ZA200300132B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979695B2 (en) * 1996-04-23 2005-12-27 Targacept, Inc. Compounds capable of activating cholinergic receptors
US6708064B2 (en) * 2000-02-24 2004-03-16 Ali R. Rezai Modulation of the brain to affect psychiatric disorders
US6432954B1 (en) * 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
EP2021325A2 (en) * 2006-05-09 2009-02-11 AstraZeneca AB Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
TWI389889B (zh) * 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
AR062860A1 (es) * 2006-09-15 2008-12-10 Astrazeneca Ab Combinaciones terapeuticas 482
WO2008091588A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
BRPI0815070A2 (pt) * 2007-07-31 2018-07-31 Astrazeneca Ab Administração transdérmica de (2s)-(4e)-n-metil-5-(3- (5-isopropoxipiridin) il-4-penten-2-amina
CN103180277A (zh) * 2010-05-20 2013-06-26 塔格塞普特股份有限公司 制备芳基取代的烯属胺的新方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409551A (en) 1972-04-14 1975-10-08 Allen & Hanburys Ltd Cyclopent a indene derivatives
US4528290A (en) 1984-01-30 1985-07-09 Eli Lilly And Company Stimulating dopamine D-1 receptors
GB8606254D0 (en) 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
FR2664600B1 (fr) 1990-07-16 1994-09-02 Rhone Poulenc Sante Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
US5723477A (en) 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
WO1996019233A2 (en) * 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
ATE334120T1 (de) 1995-01-06 2006-08-15 Targacept Inc Pharmazeutische zusammensetzungen zur vorbeugung und behandlung von störungen des zentralnervensystems
CA2197838C (en) * 1996-03-01 2004-09-28 Mark S. Miller Mouthfeel and lubricity enhancing composition
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds

Also Published As

Publication number Publication date
IL153487A0 (en) 2003-07-06
WO2002005801A3 (en) 2002-08-08
BR0112131A (pt) 2003-09-02
AU2001261828A1 (en) 2002-01-30
ZA200300132B (en) 2004-04-06
JP2004503589A (ja) 2004-02-05
EP1317267A2 (en) 2003-06-11
WO2002005801A2 (en) 2002-01-24
CA2415906A1 (en) 2002-01-24
CN1452486A (zh) 2003-10-29
US6743812B1 (en) 2004-06-01
NO20030156L (no) 2003-03-13
NO20030156D0 (no) 2003-01-13
HUP0301594A2 (hu) 2003-08-28

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
GB2358582B (en) Pharmaceutical compositions
IL152659A0 (en) Pharmaceutical composition
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
SI1524266T1 (sl) Farmacevtski sestavek
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
HUP0204555A3 (en) Pharmaceutical composition
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
GB0108470D0 (en) Pharmaceutical compositions and their use
HUP0400553A3 (en) Pharmaceutical compositions
IL154238A0 (en) Pharmaceutical composition
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
IL153487A0 (en) Pharmaceutical compositions and methods for use
IL153897A0 (en) Pharmaceutical compositions and methods for use
IL151715A0 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
GB0013503D0 (en) Pharmaceutical compositions and their uses
GB0005382D0 (en) Pharmaceutical composition
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
IL156032A0 (en) Spiroindene derivatives and pharmaceutical compositions containing the same
GB0000001D0 (en) Pharmaceutical compositions and their preparation
GB0101094D0 (en) Pharmaceutical composition